- Home
- TENX vs EDSA Comparison
TENX vs EDSA Comparison
Compare TENX & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- EDSA
- Stock Information
- Founded
- TENX 1967
- EDSA 2015
- Country
- TENX United States
- EDSA Canada
- Employees
- TENX N/A
- EDSA N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- TENX Health Care
- EDSA Health Care
- Exchange
- TENX Nasdaq
- EDSA Nasdaq
- Market Cap
- TENX 11.4M
- EDSA 11.0M
- IPO Year
- TENX N/A
- EDSA N/A
- Fundamental
- Price
- TENX $4.94
- EDSA $2.19
- Analyst Decision
- TENX Strong Buy
- EDSA Strong Buy
- Analyst Count
- TENX 4
- EDSA 1
- Target Price
- TENX $20.67
- EDSA $21.00
- AVG Volume (30 Days)
- TENX 96.4K
- EDSA 49.4K
- Earning Date
- TENX 11-13-2024
- EDSA 12-13-2024
- Dividend Yield
- TENX N/A
- EDSA N/A
- EPS Growth
- TENX N/A
- EDSA N/A
- EPS
- TENX N/A
- EDSA N/A
- Revenue
- TENX N/A
- EDSA N/A
- Revenue This Year
- TENX N/A
- EDSA N/A
- Revenue Next Year
- TENX N/A
- EDSA N/A
- P/E Ratio
- TENX N/A
- EDSA N/A
- Revenue Growth
- TENX N/A
- EDSA N/A
- 52 Week Low
- TENX $2.77
- EDSA $2.11
- 52 Week High
- TENX $41.92
- EDSA $6.46
- Technical
- Relative Strength Index (RSI)
- TENX 64.74
- EDSA 22.56
- Support Level
- TENX $4.50
- EDSA $2.11
- Resistance Level
- TENX $5.09
- EDSA $2.44
- Average True Range (ATR)
- TENX 0.27
- EDSA 0.25
- MACD
- TENX 0.01
- EDSA -0.05
- Stochastic Oscillator
- TENX 81.01
- EDSA 8.18
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.